Located in New Mexico, Urenco’s US site, UUSA, is the only operating commercial enrichment facility on US soil.
Its production represents approximately one-third of the country’s annual demand and is operated by a dedicated US workforce, under US nuclear regulation.
Watch the video below to find out more.
Please accept necessary cookies to see this video. More information can be found here
More global stories
Urenco Isotopes collaborates to strengthen future European supply chains for enriched lanthanides
Global 28 July 2026Research and Development project sees us focus on rare earth metals the uses of which may include cancer diagnosis and treatment.
Read moreResearch and Development project sees us focus on rare earth metals the uses of which may include cancer diagnosis and treatment.
Read moreUrenco publishes new Human Rights Policy
Global 22 July 2026This reinforces our commitment to respecting and promoting human rights across our operations, business relationships and supply chain.
Read moreThis reinforces our commitment to respecting and promoting human rights across our operations, business relationships and supply chain.
Read moreAbout Urenco
Urenco is an international supplier of uranium enrichment services, fuel cycle products and related solutions with sustainability at the core of our business. Operating in a pivotal area of the nuclear fuel supply chain for over 50 years, Urenco understands the importance of energy security and facilitates the reliable delivery of low carbon electricity generation for consumers around the world.
With its head office in London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Through our technology and the expertise of our people, the Urenco Group provides safe, cost effective and reliable services, operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is making a positive contribution to global climate change goals through our core business and we are committed to achieving net zero carbon emissions by 2040.
We are committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries
